Testing effectiveness (Phase 2)Study completedNCT00494585What this trial is testingCEP-701 for PH-negative MyelofibrosisWho this might be right forLeukemiaMyelofibrosis M.D. Anderson Cancer Center 27
Testing effectiveness (Phase 2)Study completedNCT00168064What this trial is testingSafety and Efficacy of Nitrogen Mustard in Treatment of Mycosis FungoidesWho this might be right forMycosis Fungoides Yaupon Therapeutics 260
Testing effectiveness (Phase 2)Study completedNCT03136185What this trial is testingBomedemstat (IMG-7289/MK-3543) in Participants With Myelofibrosis (IMG-7289-CTP-102/MK-3543-002)Who this might be right forMyelofibrosisPost-polycythemia Vera Myelofibrosis (PPV-MF)Post-essential Thrombocythemia Myelofibrosis (PET-MF)+1 more Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA) 90
Large-scale testing (Phase 3)UnknownNCT01672216What this trial is testingMulticenter Randomized Controlled Trial to Compare the Outcome of Conservative Triple Target Treatment With EMG-Biofeedback in Chronic ObstipationWho this might be right forChronic Obstipation dr. schwandner 140
Large-scale testing (Phase 3)Not Yet RecruitingNCT07357727What this trial is testingPelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)Who this might be right forPrimary Myelofibrosis (PMF)Post-polycythemia Vera Myelofibrosis (PPV-MF)Post-essential Thrombocythemia Myelofibrosis (PET-MF) Novartis Pharmaceuticals 460
Testing effectiveness (Phase 2)Study completedNCT00569660What this trial is testingPh II Study of Azacitidine in MyelofibrosisWho this might be right forMyelofibrosis M.D. Anderson Cancer Center 34
Not applicableStudy completedNCT05303480What this trial is testingDeep Phenotyping of Cutaneous T Cell Lymphoma, Type Mycosis FungoidesWho this might be right forMycosis Fungoides Centre for Human Drug Research, Netherlands 32
Post-approval studies (Phase 4)Study completedNCT00521599What this trial is testingThe Equivalent Effectiveness of 400 mcg Mometasone Furoate Using Two Different Dry Powder Inhalers in Moderate Asthmatics (Study P04828)Who this might be right forAsthma Organon and Co 672
Testing effectiveness (Phase 2)UnknownNCT02943642What this trial is testingSafety and Effectiveness of A-dmDT390-bisFv(UCHT1) Fusion Protein in Subjects With Mycosis FungoidesWho this might be right forMycosis Fungoides Angimmune LLC 162
Not applicableStudy completedNCT05106465What this trial is testingExplore Association Patterns Between Digital Outcome Assessments From the Konectom™ Platform and Magnetic Resonance Imaging (MRI) Measures of Brain Tissue DamageWho this might be right forMultiple Sclerosis (MS) Biogen 200
Post-approval studies (Phase 4)Active Not RecruitingNCT02386800What this trial is testingCINC424A2X01B Rollover ProtocolWho this might be right forPrimary MyelofibrosisPolycythemia VeraGraft Versus Host Disease+2 more Novartis Pharmaceuticals 279
Large-scale testing (Phase 3)Study completedNCT02554786What this trial is testingRandomized 52 Week Treatment Double-blind, Triple Dummy Parallel Group Study to Assess the Efficacy and Safety of QMF149 Compared to Mometasone Furoate in Participants With AsthmaWho this might be right forAsthma Novartis Pharmaceuticals 2,216
Early research (Phase 1)Study completedNCT03895112What this trial is testingMPN-RC 118 AVID200 in MyelofibrosisWho this might be right forPrimary MyelofibrosisPost-essential Thrombocythemia MyelofibrosisPost-polycythemia Vera Myelofibrosis+2 more John Mascarenhas 21
Not applicableActive Not RecruitingNCT05455931What this trial is testingReal World Observational Study of Poteligeo in Adult Patients With MF and SS (PROSPER)Who this might be right forMycosis Fungoides and Sézary Syndrome Kyowa Kirin Pharmaceutical Development Ltd 73
Large-scale testing (Phase 3)Ended earlyNCT04551053What this trial is testingTo Evaluate Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis Who Have Suboptimal Response to Ruxolitinib (LIMBER-304)Who this might be right forMyelofibrosisPrimary MyelofibrosisPost Essential Thrombocythemia Myelofibrosis+1 more Incyte Corporation 177
Large-scale testing (Phase 3)Study completedNCT03952039What this trial is testingAn Efficacy and Safety Study of Fedratinib Compared to Best Available Therapy in Subjects With DIPSS-intermediate or High-risk Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, or Post-essential Thrombocythemia Myelofibrosis and Previously Treated With RuxolitinibWho this might be right forPrimary MyelofibrosisPost-Polycythemia VeraMyelofibrosis Celgene 202
Testing effectiveness (Phase 2)WithdrawnNCT04629651What this trial is testingCaptopril Use on the Degree of Marrow Fibrosis in Bone Marrow Fibrosis/Myeloproliferative NeoplasmsWho this might be right forBone Marrow FibrosisMyeloproliferative Neoplasm Case Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT02953301What this trial is testingResminostat for Maintenance Treatment of Patients With Advanced Stage Mycosis Fungoides (MF) or Sézary Syndrome (SS)Who this might be right forMycosis FungoidesSezary SyndromeLymphoma, T-Cell, Cutaneous 4SC AG 201
Large-scale testing (Phase 3)Study completedNCT04545515What this trial is testingA Study Evaluating the Long-term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis (CF) Particpants 6 Years and Older and F/MF GenotypesWho this might be right forCystic Fibrosis Vertex Pharmaceuticals Incorporated 120
Not applicableNot Yet RecruitingNCT06066554What this trial is testingTissue and Serum Level of NLRP1, NLRP3 and Il-18 in Early Stages of mf PatientsWho this might be right forEarly Disease Onset Cairo University 60